Pretreated MRI features have the potential to identify patients with HCC in an immune-activated state and predict outcomes of immunotherapy. Trial registration The study was retrospectively registered on March 5, 2020 with registration no. [2020] 02-012-01.
Keyphrases
- contrast enhanced
- induced apoptosis
- magnetic resonance imaging
- clinical trial
- cell cycle arrest
- high resolution
- study protocol
- magnetic resonance
- phase iii
- randomized controlled trial
- oxidative stress
- type diabetes
- phase ii
- metabolic syndrome
- cell death
- climate change
- mass spectrometry
- weight loss
- photodynamic therapy